Navigation Links
Regulation of cell proliferation by the OGF-OGFr axis is dependent on nuclear localization signals
Date:4/22/2009

This release is available in Chinese.

Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that the efficacy of the Opioid Growth Factor (OGF, [Met5]-enkephalin), a clinically important antitumor agent, is dependent on nucleocytoplasmic translocation and reliant on the integrity of nuclear localization signals in the OGF receptor (OGFr). This discovery, reported in the May 09 issue of Experimental Biology and Medicine, provides new insights into the mechanism of an important endogenous system that serves as a tonically active, constitutively expressed, inhibitory regulator of DNA synthesis. This valuable information not only may contribute to understanding the etiology and pathogenesis of diseases related to this native biological system, but to the development of new agents that will enhance effectiveness in treatment.

Previous immunohistochemical and immunoelectron microscope studies have detected OGF and OGFr in both the cytoplasmic and the nuclear compartments. The OGF-OGFr axis is known to regulate cell proliferation by modulating cyclin dependent kinase inhibitors, resulting in a retardation of cells at the G1-S interface of the cell cycle. To address the question of the location and temporal relationships of OGFr nucleocytoplasmic trafficking, a probe of OGFr fused to green fluorescent protein (eGFP) was constructed. Experiments with a human cancer cell, a squamous cell carcinoma of the head and neck, revealed that translation of OGFr required approximately 5 hours, and transit into the nucleus took 8 hours; OGFr remained in the nucleus for up to 8 days. Transport through the nuclear pore and repression of cell proliferation required two of the three nuclear localization signals (NLS) in OGFr. These results show that the pathway for regulating the cell cycle by the O
'/>"/>

Contact: Dr. Ian S. Zagon
isz1@psu.edu
717-531-6409
Society for Experimental Biology and Medicine
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. A paradigm shift in immune response regulation
2. Unclear regulations obstacle to biological diversity
3. New edition of laboratory manual includes cutting-edge techniques to study gene regulation
4. Scientists shed light on evolution of gene regulation
5. Conaway Lab identifies novel mechanism for regulation of gene expression
6. CU-Boulder study suggests air quality regulations miss key pollutants
7. Carbon Disclosure Project: Worlds largest corporations seek clarity on climate change regulation
8. New insights into the regulation of PTEN tumor suppression function
9. New regulations tighten controls on restricted chemicals
10. Systems biology approach identifies nutrient regulation of biological clock in plants
11. Epigenetic regulation by the MMB/dREAM complex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... LA JOLLA, CA--Scientists at The Scripps Research Institute have ... currently the standard treatment for sheep and cattle infected ... drug may be useful in combating river blindness, a ... cause of blindness for humans. , The study ... Edition of the journal Proceedings of the National ...
(Date:2/9/2010)... is considered as one of the most successful parasites ... of intermediate hosts, including all mammals and birds. Up ... and 20% in the world are chronically infected. ... (NIMBioS) is now accepting applications for its Investigative Workshop, ... 13-15, 2010, at NIMBioS on the University of Tennessee-Knoxville ...
(Date:2/9/2010)... Research led by a scientist at Barrow Neurological ... has opened the door for the advancement of ... , These drugs block the transient receptor ... receptor responsible for the sensation of hotness from ... TRPV1 antagonists cause hyperthermia- a dangerous, fever-like rise ...
Breaking Biology News(10 mins):Scripps research team reveals how an old drug could have a new use for treating river blindness 2Scripps research team reveals how an old drug could have a new use for treating river blindness 3Scripps research team reveals how an old drug could have a new use for treating river blindness 4Modeling Toxoplasma focus of workshop 2New era of pain drugs advanced by Barrow researcher 2SSL International plc Embraces TrackWise 28R 29 Software for Global Quality and Compliance Efforts 6513 1SSL International plc Embraces TrackWise 28R 29 Software for Global Quality and Compliance Efforts 6513 2SSL International plc Embraces TrackWise 28R 29 Software for Global Quality and Compliance Efforts 6513 3CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 6509 1CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 6509 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 6509 3IPC The Hospitalist Companys Philip Vaidyan M D Named a Top Hospitalist of 2009 6505 1IPC The Hospitalist Companys Philip Vaidyan M D Named a Top Hospitalist of 2009 6505 2
... hundred years ago Lewis and Clark,s Corps of Discovery laid ... its descriptions of territory acquired through the Louisiana Purchase. While ... of living megafauna, the area ultimately yielded a wealth of ... Society of America makes clear that the process of discovery ...
... A new study comparing the composite output of 22 ... that the models do an unsatisfactory job of mimicking ... This research, published on-line Wednesday in the Royal Meteorological ... the reliability of models used to forecast global warming. ...
... billion in manufactured goods last year, according to Lux ... trillion. By 2011, over $15 billion in nano-enabled drugs ... billion in 2006. And industry experts project that nanotechnology ... food products by 2010. , Yet, despite ...
Other Biology News:New study increases concerns about climate model reliability 2New study increases concerns about climate model reliability 3FDLI, PEN co-sponsor major conference on nanotechnology 2FDLI, PEN co-sponsor major conference on nanotechnology 3
(Date:2/9/2010)... , Feb. 9 /PRNewswire-Asia-FirstCall/ -- NeoStem, ... "Company"), an international,biopharmaceutical company with operations in the ... stem cell collection network has expanded into the ... the physician group at Westlake,Orthopaedics Spine & Sports ... Company is on,track to achieve its target of ...
(Date:2/8/2010)... Space Shuttle Endeavor lifted off from NASA’s Kennedy Space Center ... Astrogenetix, a commercial biotech company created to use microgravity to ... ... (Vocus) February 8, 2010 -- Space Shuttle Endeavor ... on board the eighth scientific payload for Astrogenetix, a commercial ...
(Date:2/8/2010)... enrollment occurs five months ahead of schedule ,, TSX ... /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) ... Phase 2 clinical study of its lead drug RVX-208. ... trial, a full 5 months ahead of our original ... and our collaborators at the Cleveland Clinic. At this ...
(Date:2/8/2010)... , Feb. 8 /PRNewswire-Asia-FirstCall/ -- ... "the Company"), a leading China -based ... marketing,biopharmaceutical products, today announced a collaboration and ... and commercialize its,Nephoxil(R) pharmaceutical product for the ... Nephoxil (ferric citrate) ...
Breaking Biology Technology:Busy Southwestern Orthopedic Practice Joins the NeoStem Stem Cell Collection Network 2Busy Southwestern Orthopedic Practice Joins the NeoStem Stem Cell Collection Network 3Busy Southwestern Orthopedic Practice Joins the NeoStem Stem Cell Collection Network 4Astrogenetix Continues MRSA Vaccine Development Onboard Endeavor 2Astrogenetix Continues MRSA Vaccine Development Onboard Endeavor 3Resverlogix Completes Patient Recruitment for ASSERT Trial 2Resverlogix Completes Patient Recruitment for ASSERT Trial 3Resverlogix Completes Patient Recruitment for ASSERT Trial 43SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 23SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 33SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 4
... The EntreTech Forum ,s February 17th meeting, the panel ... and participants in the emerging bio-economy - will emphasize businesses ... play of bio-agriculture, bio-energy, ... summer we saw the impact of peaking global production of ...
... Mich., Jan. 30 Neogen Corporation,(Nasdaq: ... Rice as Neogen,s,Senior Scientific Officer. In this newly ... overall direction of Neogen,s research activities. , ... and educational background to this,new position," said James ...
... Pharmasset, Inc. (Nasdaq: VRUS ) announced today ... 29, 2009 with a select group of institutional investors ... a "registered direct" offering. The investors have agreed to ... per share resulting in gross proceeds of approximately $45.5 ...
Other Biology Technology:The EntreTech Forum Presents... Greening Of America - The Conversion of Bio-Agriculture, Bio-Energy, and Bio-Products to Eco-Sustainable Businesses 2The EntreTech Forum Presents... Greening Of America - The Conversion of Bio-Agriculture, Bio-Energy, and Bio-Products to Eco-Sustainable Businesses 3Neogen Names New Senior Science Officer; Added to S&P Index 2Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock 2Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock 3